Scarica l'app Stockscreener
2.18
5.63%
-0.13
Dopo l'orario di chiusura:
2.18
Precedente Chiudi:
$2.31
Aprire:
$2.31
Volume 24 ore:
401.22K
Relative Volume:
2.09
Capitalizzazione di mercato:
$57.03M
Reddito:
$1.79M
Utile/perdita netta:
$-70.90M
Rapporto P/E:
-0.1403
EPS:
-15.54
Flusso di cassa netto:
$-34.95M
1 W Prestazione:
+14.74%
1M Prestazione:
+56.83%
6M Prestazione:
-43.23%
1 anno Prestazione:
-0.46%
Intervallo 1D:
$2.10
$2.55
Intervallo di 1 settimana:
$1.65
$2.55
Portata 52W:
$1.26
$16.94
Senti Biosciences Inc Stock (SNTI) Company Profile
Nome
Senti Biosciences Inc
Settore
Industria
Telefono
(650) 239-2030
Indirizzo
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Confronta SNTI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
2.18 | 54.41M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-06 | Iniziato | Laidlaw | Buy |
| 2022-10-07 | Iniziato | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Borsa (SNTI) Ultime notizie
Is Senti Biosciences Inc. forming a reversal patternJuly 2025 PreEarnings & Stock Portfolio Risk Control - newser.com
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference - The Manila Times
Senti Biosciences CEO Timothy Lu to Present at Chardan's 9th Annual Genetic Medicines Conference - Quiver Quantitative
Volume spikes in Senti Biosciences Inc. stock – what they meanPortfolio Update Report & Safe Capital Investment Plans - newser.com
Evaluating Senti Biosciences Inc. with trendline analysisMarket Activity Recap & Verified Entry Point Signals - newser.com
Candlestick signals on Senti Biosciences Inc. stock today2025 Momentum Check & Weekly Breakout Watchlists - newser.com
How Senti Biosciences Inc. stock benefits from global expansionEarnings Summary Report & Entry Point Confirmation Alerts - newser.com
Senti Biosciences (NASDAQ:SNTI) Now Covered by Analysts at HC Wainwright - Defense World
H.C. Wainwright initiates Senti Biosciences with 'Buy' on cell therapy hopes - TradingView
HC Wainwright & Co. Initiates Coverage of Senti Biosciences (SNTI) with Buy Recommendation - Nasdaq
HC Wainwright Initiates Coverage on Senti Biosciences With Buy Rating, $12 Price Target - MarketScreener
Senti Biosciences stock rating initiated at Buy by H.C. Wainwright - Investing.com
What institutional flow reveals about Senti Biosciences Inc.July 2025 Action & Weekly High Potential Alerts - newser.com
Senti Biosciences Inc. recovery potential after sell offBond Market & Entry Point Confirmation Signals - newser.com
Senti Biosciences Inc. stock trendline breakdown2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com
Does Senti Biosciences Inc. show high probability of rebound2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Is Senti Biosciences Inc a good long term investmentMarket Depth Overview & Low Entry Investment Growth - earlytimes.in
Senti Bio to Present at BioJapan - MarketScreener
Oct 9, 11:30 JST — Senti Biosciences presents at BioJapan; CEO Timothy Lu to speak, booth D-53 - Stock Titan
Using data models to predict Senti Biosciences Inc. stock movementTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Custom strategy builders for tracking Senti Biosciences Inc.July 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
What analysts say about Senti Biosciences Inc stockStop Loss Placement Tips & High Yield Trading Signals - earlytimes.in
Is Senti Biosciences Inc. a candidate for recovery playRate Hike & Entry Point Strategy Guides - newser.com
Statistical indicators supporting Senti Biosciences Inc.’s strengthWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Price action breakdown for Senti Biosciences Inc.Market Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Senti Biosciences Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Unmatched Market Gains - earlytimes.in
Is It Time to Lock in Profits on Setco Automotive Limited StockRisk Mitigation Techniques & Big Data Market Reports - earlytimes.in
Senti Biosciences Inc Azioni (SNTI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Senti Biosciences Inc Azioni (SNTI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lu Timothy K | CEO |
Feb 06 '25 |
Sale |
4.36 |
545 |
2,376 |
82,082 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 04 '25 |
Sale |
4.07 |
1,297 |
5,279 |
8,803 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 06 '25 |
Sale |
4.37 |
182 |
795 |
8,621 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):